Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 4.1B | 4.0B | 4.4B | 4.4B |
Cost of revenue | 2.9B | 3.4B | 3.4B | 3.1B |
Gross profit | 1.2B | 572.9M | 1.0B | 1.3B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 799.4M | -1.9B | 885.7M | 888.4M |
Operating income | 12.4M | -104.1M | -228.1M | 16.2M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 22.4M | 13.8M | 15.3M | 15.7M |
Other income expense | — | — | — | — |
Pretax income | 10.4M | -110.2M | -561.4M | 112.8M |
Tax provision | 3.5M | 9.2M | -182.1M | 51.3M |
Net income | 6.9M | -119.4M | -379.3M | 61.5M |
Basic EPS | 0.3 | — | -15.9 | 2.6 |
Diluted EPS | 0.3 | — | -15.9 | 2.6 |
Basic average shares | 23.8M | — | 23.9M | 23.9M |
Diluted average shares | 23.8M | — | 23.9M | 23.9M |
EBITDA | 208.0M | 72.5M | -26.4M | 218.7M |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |